Events
December 2025
ACI's Life Sciences Intellectual Property Due Diligence - Boston, USA
3 - 4 December
The Life Sciences IP Due Diligence Summit is the premier forum for in-house and firm counsel, deal teams, technology scouts, and R&D leadership to explore the latest best practices in assessing, valuing, and mitigating risks around biopharma and biotech intellectual property. Now in its eighth year, this event convenes key industry voices to tackle evolving challenges in IP due diligence and to deliver actionable insights you can bring straight into your organization. HOFFMANN EITLE partner Morten Garberg will be speaking at this year's summit on the topic: “International Considerations in Your Life Sciences IP Due Diligence Review” where he will address cross-border issues that are often critical and sometimes overlooked in life sciences IP diligence.
find out more
January 2026
Pharma & Biotech Patent Litigation Summit - Amsterdam, The Netherlands
19 - 21 January
The Pharma & Biotech Patent Litigation Summit is a leading European forum bringing together more than 450 in-house counsel, IP professionals, and industry experts to explore the evolving landscape of patent disputes in the life-sciences sector. Featuring insights from top pharmaceutical and biotechnology companies, the event offers in-depth analysis of key legal and regulatory developments - including the Unified Patent Court, SPCs, biosimilar litigation, competition law, and strategies for both small- and large-molecule cases. With dedicated breakout tracks and an extensive speaker lineup, the summit provides a comprehensive, practice-focused environment for benchmarking litigation strategy, understanding emerging trends, and connecting with peers shaping the future of pharma and biotech IP. HOFFMANN EITLE will be represented at the summit by Sebastian Giese, Bianca-Lucia Vos, Lasse Weinmann, and Leonard Werner-Jones.
find out more